AI-generated summary
The authors report testing reduced graphene oxide nanocomposites combined with low-level laser therapy on MCF7 breast cancer cells in laboratory conditions. They describe cell death rising as irradiation dose increased from 8 to 32 J/cm2, with a maximum of about 50% observed with ZnO/rGO at 20% and 32 J/cm2. The authors state that 630 nm lasers were more effective than 810 nm lasers.
- Who or what was studied
- MCF7 breast cancer cells in vitro
- Wavelengths
- 630, 810 nm
- Limits stated in the abstract
- The study was conducted on cultured cancer cells in the laboratory, so results do not establish effects in humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 630 nm
- Energy density (fluence)
- 32 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Dose, Reactive oxygen species. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.